We recommend using a newer internet browser, such as Google Chrome or Microsoft Edge, to optimize your browsing experience.

Skip to main content

Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease

- Parkinson's Disease
- Completed

Study Title: Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease

Teva Identifier: TVP-1012/PM103

ClinicalTrials.gov Identifier: NCT01049984

Study Status: Completed

Trial Condition(s): Parkinson's Disease

Interventions: Drug: Rasagiline | Drug: Placebo

Study Description: Please refer to ClinicalTrials.gov for a description of the trial

ClinicalTrials.gov study records with inclusion and exclusion criteria

neurology icon for clinical trials

Key Participation Requirements

Gender: Female, Male

Age Range: 30 Years and older

Trial Duration: 12/01/2009 - 10/01/2012

Phase: Phase 4

Study Type

Interventional